Specific treatment of aneurysmal subarachnoid hemorrhage

Subarachnoid hemorrhage (SAH) secondary to a ruptured cerebral aneurysm represents a challenging clinical entity with high associated morbidity and mortality rates, for which specific management paradigms can improve outcomes. Systemic and neurological assessment and stabilization in the acute phase and prevention of rebleeding by early and definitive aneurysm treatment are critical. Further intensive care management to address potential sequelae subsequent to SAH, including delayed cerebral ischemia and other neurological and systemic complications, are also paramount to improving outcomes in this patient population.